Pathstone Holdings
RVMD icon

Pathstone Holdings’s Revolution Medicines RVMD Stock Holding History

Pathstone Holdings’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.3M Buy
6,947
+1,275
+22% +$186K ﹤0.01% 1367
2026
Q1 		$552K Buy
5,672
+1,143
+25% +$115K ﹤0.01% 1711
2025
Q4 		$361K Buy
4,529
+205
+5% +$13.4K ﹤0.01% 1880
2025
Q3 		$202K Buy
+4,324
New +$169K ﹤0.01% 2199

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Pathstone Holdings's RVMD Position: Q2 2026 in Review

Pathstone Holdings increased its Revolution Medicines (RVMD) stake by 22% in Q2 2026, buying an estimated $186K and bringing the position to 6,947 shares worth $1.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1367.

Pathstone Holdings first reported a position in RVMD in Q3 2025 and has held it in 4 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Pathstone Holdings held 6,947 shares of Revolution Medicines worth $1.3M as of Q2 2026.
  • Pathstone Holdings bought 1,275 Revolution Medicines shares in Q2 2026, an estimated $186K.
  • Revolution Medicines made up ﹤0.01% of Pathstone Holdings's portfolio in Q2 2026, its #1367 holding.
  • Pathstone Holdings first reported a position in Revolution Medicines in Q3 2025 and has held it in 4 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.